Countries in APAC serve vital growth opportunities due to the continuously growing population, including geriatric populations. The heavy investments encourage the adoption of advanced technologies in the healthcare sector. According to the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure in 2019. Furthermore, growing support from governments, continuously changing disease profiles, rising public-private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology research centers in APAC region, which creates enormous opportunities for the frozen tissue samples market players in this region.
Governments in APAC offer tax incentives, cheaper land, incubators, and direct investments to encourage the growth of local biotechnology companies by allowing them to expand their abilities and capacities, which paves way for the progress of the frozen tissue sample market. Countries such as Malaysia, Taiwan, Singapore, India, China, and Japan are among the most favorable destinations for the biotechnology research industry. Moreover, in Asian countries, frozen tissue samples are used to analyze proteomics, next-generation sequencing, and diagnostic and therapeutic biomarker exploration applications.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC frozen tissues samples market at a notable CAGR during the forecast period.
The APAC frozen tissues samples market is segmented on the basis of product type, application, end user, and country. The market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Based on application, the APAC frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the market. The APAC frozen tissues samples market, by end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest market share. Based on country, the APAC frozen tissues samples market is segmented into Australia, China, India, Japan, South Korea, and Rest of APAC.
AMS Biotechnology Ltd.; Audubon Bioscience Co; Bay Biosciences LLC; BioChain Institute Inc.; OriGene Technologies, Inc.; ProteoGenex, Inc.; REPROCELL Inc.; and ZenBio, Inc. are among the leading companies in the APAC frozen tissues samples market.